Similar Intrapatient Blood Glucose Variability with LY2963016 and Lantus(®) Insulin Glargine in Patients with Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation

INTRODUCTION: LY2963016 insulin glargine (LY IGlar) and Lantus(®) (IGlar), both with identical primary amino acid sequences, were compared in two phase 3 studies for intrapatient blood glucose variability. METHODS: ELEMENT-1 was a 52-week study in patients with type 1 diabetes (T1D), which included...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiyama, Hiroshi, Shingaki, Tomotaka, Suzuki, Yumi, Ilag, Liza L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064592/
https://www.ncbi.nlm.nih.gov/pubmed/29855972
http://dx.doi.org/10.1007/s13300-018-0450-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064592/
https://www.ncbi.nlm.nih.gov/pubmed/29855972
http://dx.doi.org/10.1007/s13300-018-0450-0

Ejemplares similares